Alarmist claims to the contrary, the FDA’s response to a massively-broad FOIA request is not evidence of a conspiracy or cover-up. Rather, it is a statement on how much information was asked for, how those claims are handled, and how many personnel are dedicated to the task.
The requested documents center on the Pfizer-BioNTech vaccine trial, information about which runs a whopping 329,000 pages. FDA officials said they could start releasing documents at a rate of 500 pages a month, in decreasing order of plaintiff priorities. These pages must be perused to determine which names need to be redacted and to identify trade secrets that need protected. Additionally, there are what the FDA calls “records that cannot be meaningfully paginated, such as data captured in spreadsheets that contain thousands of rows of data.”
A rate of 500 pages per month is consistent with processing schedules in previous FOIA requests. While all of these documents, at this rate, would take decades to provide, the plaintiffs would start getting the most documents immediately. Also of note, agencies have limited resources, and there are other requests to satisfy.
The FDA has been transparent on this topic and large amounts of vaccine data are available online. Regarding safety and effectiveness, there is likewise much published data publicly available. But expecting the agency drop everything to immediately release 329,000 redacted pages is unreasonable and, when considering the names and trade secrets that need to be removed, impossible to do in the time demanded.